Maxine Norman

414 total citations
10 papers, 301 citations indexed

About

Maxine Norman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Maxine Norman has authored 10 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Maxine Norman's work include Retinoids in leukemia and cellular processes (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Maxine Norman is often cited by papers focused on Retinoids in leukemia and cellular processes (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Maxine Norman collaborates with scholars based in United Kingdom, United States and Canada. Maxine Norman's co-authors include Christine Everett, Benjamin P. Fauber, Harvey Wong, Alberto Gobbi, Adam R. Johnson, Céline Eidenschenk, Peter Lockey, Wenjun Ouyang, Olivier René and Brenda Burton and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.

In The Last Decade

Maxine Norman

10 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxine Norman United Kingdom 8 140 93 86 77 35 10 301
Brenda Burton United Kingdom 9 102 0.7× 131 1.4× 77 0.9× 56 0.7× 31 0.9× 10 269
Olivier René Canada 11 119 0.8× 99 1.1× 74 0.9× 466 6.1× 31 0.9× 17 674
Edward Matelan Canada 8 39 0.3× 104 1.1× 65 0.8× 125 1.6× 41 1.2× 8 347
Xichen Lin China 15 80 0.6× 140 1.5× 68 0.8× 400 5.2× 43 1.2× 26 585
Jeffrey Tredup United States 10 64 0.5× 191 2.1× 71 0.8× 109 1.4× 9 0.3× 17 360
Elizabeth A. Malloy United States 9 51 0.4× 155 1.7× 69 0.8× 189 2.5× 22 0.6× 10 370
Alexander P. Ducruet United States 9 50 0.4× 453 4.9× 96 1.1× 146 1.9× 29 0.8× 10 545
Wolfgang Miltz Switzerland 8 52 0.4× 192 2.1× 73 0.8× 183 2.4× 18 0.5× 11 392
Catherine Prouty United States 14 55 0.4× 330 3.5× 54 0.6× 181 2.4× 22 0.6× 17 483
Kristen L. Arienti United States 8 22 0.2× 210 2.3× 82 1.0× 117 1.5× 26 0.7× 8 364

Countries citing papers authored by Maxine Norman

Since Specialization
Citations

This map shows the geographic impact of Maxine Norman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxine Norman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxine Norman more than expected).

Fields of papers citing papers by Maxine Norman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxine Norman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxine Norman. The network helps show where Maxine Norman may publish in the future.

Co-authorship network of co-authors of Maxine Norman

This figure shows the co-authorship network connecting the top 25 collaborators of Maxine Norman. A scholar is included among the top collaborators of Maxine Norman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxine Norman. Maxine Norman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
René, Olivier, Benjamin P. Fauber, Kerry L. Chapman, et al.. (2016). Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties. Bioorganic & Medicinal Chemistry Letters. 26(18). 4455–4461. 9 indexed citations
2.
Fauber, Benjamin P., Alberto Gobbi, Kirk Robarge, et al.. (2015). Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2907–2912. 58 indexed citations
3.
Fauber, Benjamin P., Alberto Gobbi, Pascal Savy, et al.. (2015). Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(19). 4109–4113. 10 indexed citations
4.
5.
Fauber, Benjamin P., Olivier René, Brenda Burton, et al.. (2014). Identification of tertiary sulfonamides as RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 24(9). 2182–2187. 22 indexed citations
6.
Fauber, Benjamin P., Olivier René, Gladys de Leon Boenig, et al.. (2014). Reduction in lipophilicity improved the solubility, plasma–protein binding, and permeability of tertiary sulfonamide RORc inverse agonists. Bioorganic & Medicinal Chemistry Letters. 24(16). 3891–3897. 39 indexed citations
7.
René, Olivier, Benjamin P. Fauber, Gladys de Leon Boenig, et al.. (2014). Minor Structural Change to Tertiary Sulfonamide RORc Ligands Led to Opposite Mechanisms of Action. ACS Medicinal Chemistry Letters. 6(3). 276–281. 63 indexed citations
8.
Fauber, Benjamin P., Gladys de Leon Boenig, Brenda Burton, et al.. (2013). Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc. Bioorganic & Medicinal Chemistry Letters. 23(24). 6604–6609. 49 indexed citations
9.
Norman, Maxine. (2013). Using a Hybrid Approach for a Leadership Cohort Program. Journal of Extension. 51(5). 3 indexed citations
10.
Fauber, Benjamin P., Adam R. Johnson, Brenda Burton, et al.. (2013). Syntheses of [3H2]T0901317 and a labeled structural isomer, and characterization of the dispersed labeled compounds via 19F NMR. Journal of Labelled Compounds and Radiopharmaceuticals. 57(1). 57–60. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brenda Burton Breakdown of academic impact, for papers by Olivier René Breakdown of academic impact, for papers by Edward Matelan Breakdown of academic impact, for papers by Xichen Lin Breakdown of academic impact, for papers by Jeffrey Tredup Breakdown of academic impact, for papers by Elizabeth A. Malloy Breakdown of academic impact, for papers by Alexander P. Ducruet Breakdown of academic impact, for papers by Wolfgang Miltz Breakdown of academic impact, for papers by Catherine Prouty Breakdown of academic impact, for papers by Kristen L. Arienti
Rankless by CCL
2026